SCHEMBL951175

SCHEMBL951175

CCCCc1ncc(C=O)n1Cc1ccc(C(=O)O)cc1

nearest known ligand 0.78

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 11/20 0.66
AGTR2 P50052 7/20 0.66
ABCC3 O15438 1/20 0.62
ABCC2 Q92887 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL946900 0.87 AGTR1 (0.67) AGTR1AGTR2
SCHEMBL8507705 0.86 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL1906804 0.85 AGTR1 (0.59) AGTR1AGTR2ABCC3ABCC2
SCHEMBL27406325 0.85 AGTR1 (0.55) AGTR1AGTR2
SCHEMBL27382399 0.85 AGTR1 (0.54) AGTR1AGTR2
SCHEMBL7051749 0.85 AGTR1 (0.72) AGTR1ABCC3ABCC2
SCHEMBL27405616 0.85 AGTR1 (0.54) AGTR1AGTR2
SCHEMBL7051740 0.85 AGTR1 (0.72) AGTR1ABCC3ABCC2
SCHEMBL8260760 0.84 AGTR1 (0.48) AGTR1AGTR2ABCC3ABCC2
SCHEMBL9128122 0.84 AGTR1 (0.54) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0662961-B1 PROCESS OF SYNTHESIZING USEFUL INTERMEDIATES OF SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORP (US) 1999-11-10 EP claimed
US-5565577-A Process for preparing 1-alkyaryl-2-alkyl-5-formylimidazole SMITHKLINE BEECHAM CORPORATION (US) 1996-10-15 US claimed
EP-0662961-A4 PROCESS OF SYNTHESIZING USEFUL INTERMEDIATES OF SUBSTITUTED IMIDAZOLE COMPOUNDS. SMITHKLINE BEECHAM CORP (US) 1996-07-31 EP claimed
EP-0662961-A1 PROCESS OF SYNTHESIZING USEFUL INTERMEDIATES OF SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1995-07-19 EP claimed
WO-1994006776-A1 PROCESS OF SYNTHESIZING USEFUL INTERMEDIATES OF SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1994-03-31 WO claimed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-11225655-B2 Bi-functional complexes and methods for making and using such complexes NUEVOLUTION A/S (DK) 2022-01-18 US disclosed
EP-3540059-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2019-09-18 EP disclosed
EP-2558577-B1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION AS (DK) 2018-12-12 EP disclosed
US-20130281324-A1 BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2013-10-24 US disclosed
EP-2558577-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2013-02-20 EP disclosed
WO-2011127933-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2011-10-20 WO disclosed
US-5436260-A Substituted 1-benzylimidazole-5-methylidene hydantoins WARNER-LAMBERT COMPANY (US) 1995-07-25 US disclosed
EP-0662961-A1 PROCESS OF SYNTHESIZING USEFUL INTERMEDIATES OF SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1995-07-19 EP disclosed
EP-0653937-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1995-05-24 EP disclosed
US-5308853-A Hypotensive agents, antagonists of angiotensin II WARNER-LAMBERT COMPANY (US) 1994-05-03 US disclosed
WO-1994006776-A1 PROCESS OF SYNTHESIZING USEFUL INTERMEDIATES OF SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1994-03-31 WO disclosed
CN-1081438-A Imdazole derivatives and preparation method thereof and the application on therapeutics FOURNIER IND & SANTE (FR) 1994-02-02 CN disclosed
WO-1994000120-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1994-01-06 WO disclosed
WO-1993013077-A1 ANGIOTENSIN II RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1993-07-08 WO disclosed